Immunohistochemical Markers for Metastasis in Clear Cell Renal Cell Carcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : Renal cell carcinoma (RCC) is notorious for its high metastatic potential, and 30% of RCC patients present with metastatic disease at the initial presentation and 50% of them will develop metastasis or recurrence after radical surgery. Methods : In an attempt to identify the best predictive marker(s) for metastasis in patients with clear cell RCCs (CRCCs), we examined the expression patterns of 7 metastasis/prognosis-related markers by constructing a tissue microarray including primary CRCC specimens from 30 metastatic and 60 nonmetastatic CRCCs. The markers we studied were Ki-67, MUC1, CD44s, PTEN, gelsolin, CA9 and p53. Results : The expressions of Ki-67, PTEN, CD44s, gelsolin and p53 were increased, whereas those of MUC1 and CA9 were decreased in the metastatic CRCCs compared with the non-metastatic CRCCs. The receiver operating characteristic curve-area under the curve (AUC) value of Ki-67 was 0.671, which was the highest among the 7 markers. The optimal cut-off value, sensitivity and specificity of the Ki-67 expression were 1.67%, 86.7% and 41.7%, respectively. Conclusions : These results demonstrate that the Ki-67 expression was increased in metastatic CRCCs, and it had the highest predictive value among the 7 markers. This suggests that Ki-67 could be an excellent predictive marker for metastasis in CRCC patients.
Abstract
Background : Renal cell carcinoma (RCC) is notorious for its high metastatic potential, and 30% of RCC patients present with metastatic disease at the initial presentation and 50% of them will develop metastasis or recurrence after radical surgery. Methods : In an attempt to identify the best predictive marker(s) for metastasis in patients with clear cell RCCs (CRCCs), we examined the expression patterns of 7 metastasis/prognosis-related markers by constructing a tissue microarray including primary CRCC specimens from 30 metastatic and 60 nonmetastatic CRCCs. The markers we studied were Ki-67, MUC1, CD44s, PTEN, gelsolin, CA9 and p53. Results : The expressions of Ki-67, PTEN, CD44s, gelsolin and p53 were increased, whereas those of MUC1 and CA9 were decreased in the metastatic CRCCs compared with the non-metastatic CRCCs. The receiver operating characteristic curve-area under the curve (AUC) value of Ki-67 was 0.671, which was the highest among the 7 markers. The optimal cut-off value, sensitivity and specificity of the Ki-67 expression were 1.67%, 86.7% and 41.7%, respectively. Conclusions : These results demonstrate that the Ki-67 expression was increased in metastatic CRCCs, and it had the highest predictive value among the 7 markers. This suggests that Ki-67 could be an excellent predictive marker for metastasis in CRCC patients.
참고문헌 (25)
- Jemal A, "Cancer statistics, 2007", CA Cancer J Clin, 57, pp.43~66 (2007)
- Figlin RA, "Renal cell carcinoma: management of advanced disease", J Urol, 161, pp.381~387 (1999)
- Janzen NK, "Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease", Urol Clin North Am, 30, pp.843~852 (2003)
- Fyfe G, "Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy", J Clin Oncol, 13, pp.688~696 (1995)
- Li G, "CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy", Clin Exp Metastasis, 24, pp.149~155 (2007)
- Greene FL, "AJCC cancer staging manual. 6th ed", pp.323~328 (2002), Springer-Verlag
- Eble JN, "World Health Organization classofication of tumors", pp.10~87, 2004
- Fuhrman SA, "Prognostic significance of morphologic parameters in renal cell carcinoma", Am J Surg Pathol, 6, pp.655~663 (1982)
- Selli C, "Stratification of risk factors in renal cell carcinoma", Cancer, 52, pp.899~903 (1983)
- Lam JS, "Role of molecular markers in the diagnosis and therapy of renal cell carcinoma", Urology, 66, pp.1~9 (2005)
- Kim HL, "Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma", J Urol, 173, pp.1496~1501 (2005)
- Leibovich BC, "A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials", J Urol, 174, pp.1759~1763 (2005)
- Kim HL, "Using protein expressions to predict survival in clear cell renal carcinoma", Clin Cancer Res, 10, pp.5464~5471 (2004)
- Shvarts O, "p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma", J Urol, 173, pp.725~728 (2005)
- Fujita K, "Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients", Br J Cancer, 80, pp.301~308 (1999)
- Tannapfel A, "Prognostic value of ploidy and proliferation markers in renal cell carcinoma", Cancer, 77, pp.164~171 (1996)
- Visapaa H, "Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma", Urology, 61, pp.845~850 (2003)
- Denda-Nagai K, "MUC1 in carcinoma-host interactions", Glycoconj J, 17, pp.649~658 (2000)
- Denda-Nagai K, "Absence of correlation of MUC1 expression to malignant behavior of renal cell carcinoma in experimental systems", Clin Exp Metastasis, 18, pp.77~81 (2000)
- Allory Y, "The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas", Clin Cancer Res, 11, pp.1190~1197 (2005)
- Campbell L, "Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma", Br J Cancer, 89, pp.1909~1913 (2003)
- Jiang Z, "Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study", Lancet Oncol, 7, pp.556~564 (2006)
- Kosari F, "Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness", Clin Cancer Res, 11, pp.5128~5139 (2005)
- Rioux-Leclercq N, "Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinoma", Hum Pathol, 35, pp.1279~1284 (2004)
- Thompson RH, "Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up", Cancer Res, 66, pp.3381~3385 (2006)